News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

uniQure (QURE): A Busted Biotech IPO Worth Owning



8/22/2017 6:22:03 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
* Today's busted-IPO deep dive is on uniQure. Its gene-based therapies have demonstrated life-changing results in patients with Hemophilia B.

* While years away from commercialization, it has several attractive traits including a major collaboration deal with Bristol-Myers Squibb.

* This promising Tier 4 developmental concern seems worthy of a small stake within a well-diversified biotech portfolio at current prices.

Read at Seeking Alpha


comments powered by Disqus
uniQure
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES